(Q37715274)
Statements
Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy (English)
Liz Y Han
Tom van Hagen
Shibani Nicum
Karen Thomas
Michelle Harrison
Panagiotis Papadopoulos
Peter Blake
Desmond P J Barton
Martin Gore